Home / Inspections / 1191870

FDA Inspection 1191870 — UF Reproductive Medicine at Springhill

UF Reproductive Medicine at Springhill — FEI 3003926999

The FDA completed an inspection of UF Reproductive Medicine at Springhill on November 7, 2022 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 7, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Gainesville, FL (United States)

Facility

Other inspections at this facility

  • 1303158 (NAI Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1092804 (NAI Thu Jun 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 987875 (NAI Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895060 (NAI Thu Sep 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 735060 (VAI Mon Jul 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources